US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIOHARVEST SCIENCES INC

7.66

+0.38215.25%

Volume:6.95K

Turnover:51.59K

Market Cap:132.77M

PE:-15.10

High:7.66

Open:7.16

Low:7.16

Close:7.28

Loading ...

Overview Company News Filings

Bioharvest Sciences Inc. Unveils Informed Sport-Certified VINIA DailyChews 2X Formula to Boost Athletic Performance and Blood Flow

BioHarvest Secures Contract to Develop Plant-Based Fragrance Using AI and Botanical Synthesis

BioHarvest Sciences Reports 47% Increase in Q1 2025 Revenues to $7.9 Million, Surpassing Guidance

BioHarvest Sciences Inc. - Common Stock Q1 EPS $(0.13), Inline, Sales $7.86M Miss $11.93M Estimate

BioHarvest Sciences Advances CDMO Contract to Stage 2 with Nasdaq-Listed Pharma Company

BioHarvest Sciences initiated with a Buy at Craig-Hallum

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock?

Kymera Therapeutics (KYMR) Moves 13.8% Higher: Will This Strength Last?

BioHarvest Sciences Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

BioHarvest Sciences Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

Calendar of U.S. Earnings Expected in the Week Ahead

Bioharvest Sciences Inc expected to post a loss of 12 cents a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Strength Seen in BioHarvest Sciences Inc. (BHST): Can Its 12.7% Jump Turn into More Strength?

BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BHST/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BHST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BHST\",,,,,undefined,":{"symbol":"BHST","market":"US","secType":"STK","nameCN":"BIOHARVEST SCIENCES INC","latestPrice":7.6621,"timestamp":1749758400000,"preClose":7.28,"halted":0,"volume":6948,"delay":0,"floatShares":12566368,"shares":17327717,"eps":-0.507337,"marketStatus":"Pre-Mkt","change":0.3821,"latestTime":"06-13 06:28:18 EDT","open":7.16,"high":7.6621,"low":7.16,"amount":51588.9743436,"amplitude":0.06897,"askPrice":9.91,"askSize":2000,"bidPrice":5.03,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.507337,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749821400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":7.6621,"postHourTrading":{"tag":"盘后","latestPrice":7.6621,"preClose":7.6621,"latestTime":"18:38 EDT","volume":82,"amount":618.2,"timestamp":1749767937414},"volumeRatio":0.4311942439858131},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BHST\",,,,,undefined,":{"symbol":"BHST","floatShares":12566368,"roa":"-23.05%","roe":"-5955.96%","lyrEps":-0.797404,"volumeRatio":0.4311942439858131,"shares":17327717,"dividePrice":0,"high":7.6621,"amplitude":0.06897,"preClose":7.28,"low":7.16,"week52Low":4.7237,"pbRate":"-151.56","psRate":"4.79","week52High":7.86,"institutionHeld":0,"latestPrice":7.6621,"committee":-0.904762,"eps":-0.507337,"divideRate":0,"volume":6948,"delay":0,"ttmEps":-0.507337,"open":7.16,"prevYearClose":6.18,"prevWeekClose":6.96,"prevMonthClose":6.2625,"prevQuarterClose":6.19,"fiveDayClose":6.88,"twentyDayClose":6.6,"sixtyDayClose":6.12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BHST\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540050430","title":"Bioharvest Sciences Inc. Unveils Informed Sport-Certified VINIA DailyChews 2X Formula to Boost Athletic Performance and Blood Flow","url":"https://stock-news.laohu8.com/highlight/detail?id=2540050430","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540050430?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:01","pubTimestamp":1749034882,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc. Unveils Informed Sport-Certified VINIA DailyChews 2X Formula to Boost Athletic Performance and Blood Flow. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via Newsfile  on June 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL7ZGYQh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2537293823","title":"BioHarvest Secures Contract to Develop Plant-Based Fragrance Using AI and Botanical Synthesis","url":"https://stock-news.laohu8.com/highlight/detail?id=2537293823","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537293823?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:31","pubTimestamp":1747830665,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. has announced a new contract through its Botanical Synthesis CDMO Services division to develop a plant-based fragrance compound. The agreement, which includes milestone-based payments and a non-disclosure agreement for Stage 1, expands BioHarvest's platform into the fragrance market. Utilizing its advanced AI-assisted research capabilities, the company identified specific plant species to develop a cell bank for efficient production of fragrance molecules. Stage 1 will use BioHarvest's proprietary Botanical Synthesis platform to replicate and multiply the plant's targeted cells. A successful outcome could lead to Stage 2, involving production in liquid media, paving the way for future manufacturing. CEO Ilan Sobel highlighted the contract as validation of the platform's ability to deliver scalable solutions while conserving threatened plant species.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL7CMSjM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2535680390","title":"BioHarvest Sciences Reports 47% Increase in Q1 2025 Revenues to $7.9 Million, Surpassing Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2535680390","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535680390?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:51","pubTimestamp":1747342277,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc., a company specializing in Botanical Synthesis technology, reported a significant increase in its first quarter 2025 financial results. Revenues surged by 47% year-over-year to $7.9 million, surpassing management's guidance. This growth was primarily driven by the success of the VINIA product line, which expanded its active subscriber base to over 50,000 as of February 2025. Gross profit for the quarter rose by 53% to $4.6 million, representing 58.5% of total revenue, compared to $3.0 million or 56.2% in the same period the previous year. The improvement in gross margin was attributed to enhanced manufacturing scale and yields. Looking forward, BioHarvest anticipates continued expansion in its Products and Services business units, aiming to grow the \"VINIA inside\" product lines and subscriber bases, along with adding new CDMO partners. The company remains focused on leveraging its Botanical Synthesis platform to meet rising global consumer health and wellness t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL6x5W0x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2535870611","title":"BioHarvest Sciences Inc. - Common Stock Q1 EPS $(0.13), Inline, Sales $7.86M Miss $11.93M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535870611","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535870611?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:11","pubTimestamp":1747339876,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. - Common Stock Q1 EPS $(0.13), Inline, Sales $7.86M Miss $11.93M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45451679/bioharvest-sciences-inc-common-stock-q1-eps-0-13-inline-sales-7-86m-miss-11-93m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2535781719","title":"BioHarvest Sciences Advances CDMO Contract to Stage 2 with Nasdaq-Listed Pharma Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2535781719","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535781719?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:23","pubTimestamp":1747081431,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. has announced the successful completion of Stage 1 in its CDMO contract with a Nasdaq-listed pharmaceutical company, marking a significant milestone in the development of a novel plant-based compound. The completion of this stage validates the company's proprietary Botanical Synthesis platform, which effectively isolated and multiplied target plant cells to develop active pharmaceutical compounds. Moving forward to Stage 2, BioHarvest will focus on scaling biomass and refining compound concentration to meet commercial production demands. This progress underscores the platform's versatility and enhances BioHarvest's analytical capabilities for future projects.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL90Wz7N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2533853795","title":"BioHarvest Sciences initiated with a Buy at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2533853795","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533853795?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:41","pubTimestamp":1746445282,"startTime":"0","endTime":"0","summary":"Craig-Hallum initiated coverage of BioHarvest Sciences (BHST) with a Buy rating and $15 price target Published first on TheFly – the ultimate sourc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioharvest-sciences-initiated-with-a-buy-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioharvest-sciences-initiated-with-a-buy-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","BHST"],"gpt_icon":0},{"id":"2532074772","title":"BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2532074772","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532074772?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:30","pubTimestamp":1746102600,"startTime":"0","endTime":"0","summary":"Rehovot, Israel-- - BioHarvest Sciences Inc.   , a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the first quarter ended March 31, 2025 after market close on Thursday, May 15, 2025.Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on Thursday, May 15, 2025 to discuss the Company's first quarter 2025 financial results, provide a corporate update, and conclude with a question-and-answer session from telephone participants. To participate, please use the following information:. First Quarter 2025 Earnings Conference CallDate: Thursday, May 15, 2025Time: 4:30 p.m. Eastern timeU.S./Canada Dial-in: 1-877-300-8521International Dial-in: 1-412-317-6026Conference ID: 2552254Webcast: BHST Q1 2025 Earnings Conference Call. Please dial in at least 10 minutes before the start of the call to ensure timely participation.A telephone playback of the call will be available through Th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-sciences-host-first-quarter-123000420.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-host-first-quarter-123000420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HST","EML","BHST"],"gpt_icon":0},{"id":"2527419189","title":"BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527419189","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527419189?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:20","pubTimestamp":1744716000,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc. BHST shares ended the last trading session 5.2% higher at $5.90. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 4.1% loss over the past four weeks.The rise in share price is attributable to positive investor sentiment around the company’s proprietary technology platform to grow plant-based molecules, without the need to grow the underlying plant.This company is expected to post quarterly loss of $0.15 per share in its upcoming report, which represents a year-over-year change of +57.1%. Revenues are expected to be $7.75 million, up 45.1% from the year-ago quarter.BioHarvest Sciences Inc. belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Apellis Pharmaceuticals, Inc. APLS, closed the last trading session 0.5% lower at $19.33. Over the past month, APLS has returned -21.3%.BioHarvest Sciences Inc.  : Free Stock Analysis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-inc-bhst-soars-112000604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756168.USD","APLS","BK4585","BK4505","BK4183","LU1093756325.SGD","BHST","BK4588","BK4139"],"gpt_icon":0},{"id":"2526516775","title":"Kymera Therapeutics (KYMR) Moves 13.8% Higher: Will This Strength Last?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526516775","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526516775?lang=en_us&edition=fundamental","pubTime":"2025-04-10 22:10","pubTimestamp":1744294200,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics, Inc.  shares ended the last trading session 13.8% higher at $23.95. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 36.7% loss over the past four weeks.Shares rallied due to broader market optimism following President Trump's tweet that there would be a 90-day pause on reciprocal tariffs for non-retaliating countries. Kymera also announced the appointment of Noah Goodman as its new Chief Business Officer.For Kymera Therapeutics, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on KYMR going forward to see if this recent jump can turn into more strength down the road.Kymera Therapeutics is a member of the Zacks Medical - Biomedical and Genetics industry. One other stock in the same industry, B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kymera-therapeutics-kymr-moves-13-141000475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KYMR","BK4139","BK4183","BHST"],"gpt_icon":0},{"id":"2525063860","title":"BioHarvest Sciences Price Target Maintained With a $14.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2525063860","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525063860?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:00","pubTimestamp":1744110000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BHST/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2025 07:00 ET (11:00 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2524460965","title":"BioHarvest Sciences Full Year 2024 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2524460965","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524460965?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:19","pubTimestamp":1743592768,"startTime":"0","endTime":"0","summary":"AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.NasdaqGM:BHST Earnings and Revenue Growth April 2nd 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue was in line with analyst estimates. Earnings per share  missed analyst estimates by 1.9%.Looking ahead, revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Personal Products industry in the US.The company's shares are down 3.9% from a week ago.Every company has them, and we've spotted   3 warning signs for BioHarvest Sciences   (of which 1 shouldn't be ignored!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-full-2024-earnings-111928178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BHST"],"gpt_icon":0},{"id":"2524594972","title":"BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2524594972","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524594972?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:05","pubTimestamp":1743451500,"startTime":"0","endTime":"0","summary":"Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to $25.2 Million. CDMO Division Secures Anchor Partnership with Tate & Lyle to Develop Next Generation of Plant-Based Sweeteners. Rehovot, Israel-- - BioHarvest Sciences Inc.   , a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2024.Total revenues for the fourth quarter of 2024 increased 62% year-over-year to $7.3 million, exceeding prior management guidance, with gross margins expanding by 600 basis points to 57% of revenue.Ilan Sobel, CEO of BioHarvest Sciences, said: \"The fourth quarter of 2024 marked another period of strong execution across both our Products and CDMO business units, highlighted by 99% year-over-year revenue growth that consistently exceeded guidance. Our VINIA product lines continued to outper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-sciences-reports-fourth-quarter-200500707.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-reports-fourth-quarter-200500707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4183","BK4139","CDMO","BHST"],"gpt_icon":0},{"id":"2523915166","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2523915166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523915166?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:00","pubTimestamp":1743415200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCNO","BK4178","TTGT","UNF","AYI","RANI","CAG","BK4200","MSM","WPRT","BK4584","NNOX","BK4023","REKR","SPWH","LNZA","BK4524","BK4141","FTCI","PVLA","BLRX","PRGS","SGML","RH","PENG","APOG","CELC","BK4167","SLP","PVH","LOAR","BK4086","LU0054578231.USD","AMC","CUK","FC","GWH","LPRO","BW","PROK","ANGO","DARE","BK4007","BHST","LW","LNN","OMER","RDUS","SPIR"],"gpt_icon":0},{"id":"2523680775","title":"Bioharvest Sciences Inc  expected to post a loss of 12 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2523680775","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523680775?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:16","pubTimestamp":1743192980,"startTime":"0","endTime":"0","summary":"Bioharvest Sciences Inc <8MV0.MU> expected to post a loss of12cents a share - Earnings Preview Bioharvest Sciences Inc 8MV0.MU  is expected to report resultson March 31 for the period ending December ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB1QT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHST"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REKR","SKYH","CRDL","PRGS","SLRN","DARE","SGML","CELC","ADCT","WGO","GWH","KYTX","LNZA","PVLA","CLSD","FBIO","NNOX","BCAB","SPWH","EDAP","BHST","PENG","TLSI","TSAT","LULU","INR","NCNO","MDAI","WBA","WKSP","FTCI","FEMY","BW","UNCY","RANI","NUTX","ANGO","BRZE","PVH","SDST","IKT","CALC","RLMD","GOVX","AFMD","FC","INMB","GEVO","BLRX","ATAI"],"gpt_icon":0},{"id":"2520574575","title":"Strength Seen in BioHarvest Sciences Inc. (BHST): Can Its 12.7% Jump Turn into More Strength?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520574575","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520574575?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:51","pubTimestamp":1742219460,"startTime":"0","endTime":"0","summary":"BioHarvest Sciences Inc.  shares ended the last trading session 12.7% higher at $5.85. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 7.3% loss over the past four weeks.Earlier this month, the company announced data from an in vitro test on its proprietary new Olive Cell compound, which demonstrated reduced fat accumulation in human liver cells. Fat accumulation in the liver is a leading cause of non-alcohol fatty liver disease, which affects around 30-40% of adults in the United States. This might have driven the recent share price rally.BioHarvest Sciences Inc. is a member of the Zacks Medical - Biomedical and Genetics industry. One other stock in the same industry, Arvinas, Inc. , finished the last trading session 1.4% lower at $8.43. ARVN has returned -51.6% over the past month.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strength-seen-bioharvest-sciences-inc-135100013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BHST","BK4183","BK4007","ARVN"],"gpt_icon":0},{"id":"2520369525","title":"BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2520369525","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520369525?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:30","pubTimestamp":1742214600,"startTime":"0","endTime":"0","summary":"Rehovot, Israel-- - BioHarvest Sciences Inc.   , a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024 after market close on Monday, March 31, 2025.Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on Monday, March 31, 2025, to discuss the Company's fourth quarter and full year 2024 financial results, provide a corporate update, and conclude with a question-and-answer session from telephone participants. To participate, please use the following information:. Fourth Quarter FY2024 Results Conference CallDate: Monday, March 31, 2025Time: 4:30 p.m. Eastern timeU.S./Canada Dial-in: 1-844-825-9789International Dial-in: 1-412-317-5180Conference ID: 10197712Webcast: BHST Q4 FY2024 Earnings Conference Call. Please dial in at least 10 minutes before the start of the call to ensure timely participation.A telephone playback o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-sciences-host-fourth-quarter-123000960.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-host-fourth-quarter-123000960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EML","HST","BHST"],"gpt_icon":0},{"id":"2517157728","title":"BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157728","media":"Newsfile","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157728?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:30","pubTimestamp":1741267800,"startTime":"0","endTime":"0","summary":"Vancouver, British Columbia and Rehovot, Israel-- - BioHarvest Sciences Inc. , a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the 37th Annual Roth Conference taking place on March 16-18, 2025.CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the duration of the event.37th Annual Roth Conference for Growth CompaniesDate: March 16-18, 2025Location: Laguna Cliffs Marriott Resort & Spa - Dana Point, CAFormat: 1x1s Meetings. This press release may contain \"forward-looking statements\". \"Forward-looking statements\" describe future expectations, plans, results, or strategies and are generally preceded by words such as \"may,\" \"future,\" \"plan\" or \"planned,\" \"will\" or \"should,\" \"expected,\" \"anticipates,\" \"draft,\" \"eventually\" or \"projected.\" You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumsta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-sciences-participate-37th-annual-133000257.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-participate-37th-annual-133000257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4183","BHST","CDMO","BK4139"],"gpt_icon":0},{"id":"2516467120","title":"BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2516467120","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516467120?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"Non-Alcoholic Fatty Liver Disease  Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health. The Company attributes the positive test results of reducing fat accumulation in liver cells to the high levels of Verbascoside  in BioHarvest's Olive Cell compound. Hepatic fat accumulation can progress from simple NAFLD to non-alcoholic steatohepatitis  which includes hepatocellular injury, inflammation, and fibrosis. In more severe cases, complications such as liver cirrhosis and hepatocellular carcinoma may arise. NASH, the more severe form of NAFLD, affects 3-5% of US adult population.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-vitro-testing-shows-proprietary-133000517.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-vitro-testing-shows-proprietary-133000517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BHST","CDMO","BK4183","BK4139"],"gpt_icon":0},{"id":"2512344384","title":"BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2512344384","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512344384?lang=en_us&edition=fundamental","pubTime":"2025-02-20 19:10","pubTimestamp":1740049838,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at BioHarvest Sciences Inc.'s  future prospects. BioHarvest Sciences Inc. operates as a biotechnology company. With the latest financial year loss of US$13m and a trailing-twelve-month loss of US$17m, the US$106m market-cap company amplified its loss by moving further away from its breakeven target. The most pressing concern for investors is BioHarvest Sciences' path to profitability – when will it breakeven?Below we will provide a high-level summary of the industry analysts’ expectations for the company.BioHarvest Sciences is bordering on breakeven, according to the 3 American Personal Products analysts. They anticipate the company to incur a final loss in 2025, before generating positive profits of US$1.9m in 2026. Therefore, the company is expected to breakeven just over a year from today. What rate will the company have to grow year-on-year in order to breakeven on this date?Using a line of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-inc-nasdaq-bhst-111038993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","IE00BKPKM429.USD",".IXIC","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4112","LU2210150020.SGD","TQQQ","BK4585","NVIW.SI","MNQmain","BK4588","NQmain","BHST","NDAQ","LU2210149790.SGD","USAW.SI","PSQ","SQQQ","QLD","LU2095319765.USD","IE00B3QW5Z07.USD","TSYW.SI","BK4183","USJW.SI"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BHST\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"BHST","fiscalQuarterEnding":"2025/03","expectedEps":-0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-03-31","symbol":"BHST","fiscalQuarterEnding":"2024/12","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2024-11-25","symbol":"BHST","fiscalQuarterEnding":"2024/09","expectedEps":-0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1732510800000,"reportTimeType":"post","actualEps":-0.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BHST\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BHST\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1746504000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BHST\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BHST","date":"2025-06-12","current":-14.549686,"percent":0,"low":-14.549686,"twenty":-8.650091,"median":-6.249745,"eighty":-5.698774,"high":-4.869221,"avg":-7.351452,"sd":2.450279,"marketCap":126145779},"quantilePoints":[{"date":"2024-11-15","current":-6.399593,"twenty":-6.399593,"median":-6.399593,"eighty":-6.230275,"marketCap":103865403.61},{"date":"2024-11-22","current":-6.578535,"twenty":-6.670268,"median":-6.505104,"eighty":-6.399593,"marketCap":106769625.28},{"date":"2024-11-29","current":-6.258648,"twenty":-6.636081,"median":-6.415633,"eighty":-6.252153,"marketCap":107598684.56},{"date":"2024-12-06","current":-5.919619,"twenty":-6.587677,"median":-6.266885,"eighty":-6.160277,"marketCap":101770093.44},{"date":"2024-12-13","current":-6.394276,"twenty":-6.549163,"median":-6.254589,"eighty":-6.178912,"marketCap":109930392.21},{"date":"2024-12-20","current":-6.319174,"twenty":-6.425257,"median":-6.250529,"eighty":-6.161351,"marketCap":108639237.75},{"date":"2024-12-27","current":-6.085853,"twenty":-6.399593,"median":-6.236881,"eighty":-6.142323,"marketCap":104627983.18},{"date":"2025-01-03","current":-6.14327,"twenty":-6.399593,"median":-6.232093,"eighty":-6.143081,"marketCap":105615097.28},{"date":"2025-01-10","current":-6.158969,"twenty":-6.396403,"median":-6.227192,"eighty":-6.142891,"marketCap":105884985.66},{"date":"2025-01-17","current":-5.951235,"twenty":-6.349215,"median":-6.186337,"eighty":-6.122214,"marketCap":102313635.51},{"date":"2025-01-24","current":-5.363116,"twenty":-6.317967,"median":-6.163655,"eighty":-6.097645,"marketCap":92202685.6},{"date":"2025-01-31","current":-5.043213,"twenty":-6.296448,"median":-6.158356,"eighty":-5.955891,"marketCap":86702920.34},{"date":"2025-02-07","current":-5.636086,"twenty":-6.26359,"median":-6.152222,"eighty":-5.700475,"marketCap":96895588.66},{"date":"2025-02-14","current":-5.636635,"twenty":-6.257248,"median":-6.14327,"eighty":-5.662603,"marketCap":96905033.24},{"date":"2025-02-21","current":-5.352019,"twenty":-6.254224,"median":-6.142323,"eighty":-5.638701,"marketCap":92011910},{"date":"2025-02-28","current":-5.232483,"twenty":-6.250215,"median":-6.121412,"eighty":-5.636086,"marketCap":89956842},{"date":"2025-03-07","current":-5.233692,"twenty":-6.246545,"median":-6.107216,"eighty":-5.388668,"marketCap":89977636},{"date":"2025-03-14","current":-5.230971,"twenty":-6.236154,"median":-6.085853,"eighty":-5.363255,"marketCap":89930851},{"date":"2025-03-21","current":-6.439134,"twenty":-6.236154,"median":-6.085853,"eighty":-5.365464,"marketCap":110701585},{"date":"2025-03-28","current":-6.500918,"twenty":-6.257948,"median":-6.110985,"eighty":-5.373286,"marketCap":111763774},{"date":"2025-04-04","current":-7.7024,"twenty":-6.306302,"median":-6.125426,"eighty":-5.388668,"marketCap":99461095},{"date":"2025-04-11","current":-7.447443,"twenty":-6.399593,"median":-6.142797,"eighty":-5.431083,"marketCap":96168829},{"date":"2025-04-17","current":-7.541375,"twenty":-6.500918,"median":-6.146873,"eighty":-5.432046,"marketCap":97381769},{"date":"2025-04-25","current":-8.856418,"twenty":-6.64761,"median":-6.15668,"eighty":-5.543418,"marketCap":114362932},{"date":"2025-05-02","current":-8.923513,"twenty":-6.803286,"median":-6.161237,"eighty":-5.608487,"marketCap":115229318},{"date":"2025-05-09","current":-8.681974,"twenty":-7.436708,"median":-6.168312,"eighty":-5.636086,"marketCap":112110328},{"date":"2025-05-16","current":-8.628299,"twenty":-7.527956,"median":-6.19099,"eighty":-5.636086,"marketCap":111417220},{"date":"2025-05-23","current":-12.291287,"twenty":-7.795929,"median":-6.201241,"eighty":-5.636635,"marketCap":106565459},{"date":"2025-05-30","current":-12.691004,"twenty":-8.282093,"median":-6.232093,"eighty":-5.644898,"marketCap":110031002},{"date":"2025-06-06","current":-13.750253,"twenty":-8.588901,"median":-6.237873,"eighty":-5.685074,"marketCap":119214692},{"date":"2025-06-12","current":-14.549686,"twenty":-8.650091,"median":-6.249745,"eighty":-5.698774,"marketCap":126145779}],"updateTime":1749810498215}}}